Financial results for the first half of 2006 | Innate Pharma

Wed, 08/30/2006 - 18:47

Innate Pharma S.A. announced today its results for the six months ended June 30, 2006.

PR in english	184.09 KB
CP en français	209.44 KB

Company
Science
Products
- Pipeline overview
- ------------------
- Lacutamab
- IPH4502
- Monalizumab
- Other Clinical Stage Assets
  - IPH6501
  - IPH6101
  - IPH6401
  - IPH5201
  - IPH5301
Partnering
Investors
Media
Careers